Generation of mice with combined Hexa Gly269Ser KI or KO and Neu3 KO alleles to create new models of GM2 gangliosidoses
Biology Open · 15.09.2025 · 14 (9)
DOI: 10.1242/bio.062045 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biology Open, online erschienen am 30.09.2025. Verfasst von Emily N Barker und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry and Medical Genetics, University of Manitoba, Winnipeg, CanadaR3T 2N2. Hauptthemen laut MEDLINE: Disease Models, Animal, Alleles, Gangliosidoses, GM2, beta-Hexosaminidase alpha Chain. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: CIHR, Research Manitoba, Autism Speaks.
Abstract (Originalsprache)
The GM2 gangliosidoses are lysosomal storage disorders exhibiting a spectrum of neurological phenotypes ranging from childhood death to debilitating adult-onset neurological impairment. To date, no mouse model harbouring a specific human mutation causing GM2 gangliosidosis has been created. We used CRISPR/Cas9 to generate knockin (KI) mice with the common adult-onset Hexa Gly269Ser variant as well as knockout (KO) mice with Hexa mutations expected to cause complete HexA deficiency. We also created Neu3 KO alleles that combined with Hexa KO or KI alleles were expected to create acute and chronic models of GM2 gangliosidosis, respectively. However, both models accumulated GM2 ganglioside throughout the brain when compared to controls (CON), and exhibited progressive loss of reflexes, gait abnormalities, and premature death by 24 weeks of age. Although survival and behavioural phenotypes did not differ between KO and KI models, the KI model had substantial Hexa mRNA and evidence of GM2 turnover. This KI model will be useful for developing gene editing to correct the variant causing the Gly269Ser substitution and its novel biochemical phenotype suggests it may be suitable for testing therapies that treat partial β-hexosaminidase A deficiency.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biochemistry and Medical Genetics, University of Manitoba, Winnipeg, CanadaR3T 2N2.
- Genetics and Molecular Pathology, SA Pathology at Women's and Children's Hospital, 72 King William Road, North Adelaide 5006, Australia.
- School of Medicine, University of Adelaide, Adelaide 5005, Australia.
- Physiology & Pathophysiology, University of Manitoba, Winnipeg, CanadaR3T 2N2.
- PrairieNeuro Research Centre, Kleysen Institute for Advanced Medicine, Health Sciences Centre, Winnipeg, CanadaR3E 0Z3.
- Pathology, University of Manitoba, Winnipeg, CanadaR3T 2N2.
ORCID-Profile: Richard Hemming, Shreya H Dhume, Shirley Yu, Barbara Triggs-Raine
Förderung
- CIHR
- Research Manitoba
- Autism Speaks
- Natural Sciences and Engineering Council of Canada
- Canadian Institutes of Health Research
Zitieren
APA
Barker, E. N., Ashiri, M., Saville, J. T., Hemming, R., Furletti, N., Dhume, S. H., Yu, S., Anjos, E., Wu, X., Fresnoza, A., Merz, D. C., Jackson, M., Del Bigio, M. R., Siddiqui, T. J., Fuller, M., Mark, B. L., & Triggs-Raine, B. (2025). Generation of mice with combined Hexa Gly269Ser KI or KO and Neu3 KO alleles to create new models of GM2 gangliosidoses. Biology Open, 14(9). https://doi.org/10.1242/bio.062045
Vancouver
Barker EN, Ashiri M, Saville JT, Hemming R, Furletti N, Dhume SH, et al. Generation of mice with combined Hexa Gly269Ser KI or KO and Neu3 KO alleles to create new models of GM2 gangliosidoses. Biology Open. 2025;14(9). doi:10.1242/bio.062045
BibTeX
@article{Barker2025,
author = {Barker, Emily N and Ashiri, Mehrafarin and Saville, Jennifer T and Hemming, Richard and Furletti, Nikolas and Dhume, Shreya H and Yu, Shirley and Anjos, Elaine and Wu, Xiaoli and Fresnoza, Agnes and Merz, David C and Jackson, Mike and Del Bigio, Marc R and Siddiqui, Tabrez J and Fuller, Maria and Mark, Brian L and Triggs-Raine, Barbara},
title = {Generation of mice with combined Hexa Gly269Ser KI or KO and Neu3 KO alleles to create new models of GM2 gangliosidoses},
journal = {Biology Open},
year = {2025},
volume = {14},
number = {9},
doi = {10.1242/bio.062045}
}
EUVIMED